Patents – Page 5
-
Business
Mitsui to close several Japanese plants and expand in China
Radical restructuring brings firm focus on speciality isocyanates
-
-
Business
AstraZeneca claims quashed in heartburn drug patent case
Nexium rival does not infringe on patent, court rules
-
BusinessNew wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
BusinessTwo way traffic for Chinese drug licensing
Western companies are seeing more value in Chinese innovation
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
BusinessLilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
Ups and downs for erectile dysfunction drugs
First new drug in a decade approved in Europe as Viagra patent expires
-
NewsUS supreme court rules genes can't be patented
Breast cancer test company at centre of case can still rely on patents on non-naturally occurring DNA
-
Business
Pfizer and Takeda win $2.15bn in patent payout
Teva and Sun fined for selling generics before patent expiry
-
Business
Japanese pharma opens compound vaults
Molecule libraries to be screened for neglected diseases
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
Business
DuPont and Monsanto settle Roundup dispute
Firms drop expensive ongoing litigation in favour of a licensing deal
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
Business
Russian investment vehicle sets sights on innovative drugs
Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
-
BusinessUK considers patent rule change for trials
Government to change law that organisations say makes the country less appealing as a location for clinical trials
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
Business
Single EU patent agreed for 2014
European commission says long awaited single patent will cut cost of filing by 87%